Cargando…
Potential clinical utility of plasma D-dimer levels among women with cervical cancer in Lagos, Nigeria
The link between plasma D-dimer levels and underlying malignancy has been established. How this translates in clinical practice as a marker of detection and prognosis of cervical cancer (CC) is still unknown. This study compared the plasma D-dimer levels in women with and without CC and assessed the...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cancer Intelligence
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9937069/ https://www.ncbi.nlm.nih.gov/pubmed/36816787 http://dx.doi.org/10.3332/ecancer.2023.1501 |
_version_ | 1784890354766446592 |
---|---|
author | Tietie, Lucky E Okunade, Kehinde S SoibI-Harry, Adaiah P John-Olabode, Sarah O Anorlu, Rose I |
author_facet | Tietie, Lucky E Okunade, Kehinde S SoibI-Harry, Adaiah P John-Olabode, Sarah O Anorlu, Rose I |
author_sort | Tietie, Lucky E |
collection | PubMed |
description | The link between plasma D-dimer levels and underlying malignancy has been established. How this translates in clinical practice as a marker of detection and prognosis of cervical cancer (CC) is still unknown. This study compared the plasma D-dimer levels in women with and without CC and assessed the associations between plasma D-dimer levels and the stage and grade of CC. It was a comparative cross-sectional study of 65 women with histological diagnosis of CC and an equal number of age-matched cancer-free women enrolled at the University Teaching Hospital in Lagos, Nigeria. Participants’ sociodemographic and clinical data as well as venous blood samples for estimation of plasma D-dimer were collected for statistical analyses. A receiver operating characteristic (ROC) analysis is performed to select the cut-off value of plasma D-dimer for differentiating CC from non-cancer. There was a statistically significant difference in the median levels of plasma D-dimer of women with CC and their cancer-free comparison groups (3,120 (1,189–4,515) versus 210 (125–350) ng/mL; p = 0.001). A plasma D-dimer value of 543 ng/mL was chosen in a ROC analysis as the discriminatory cut-off to differentiate CC from non-cancer. There were significant associations between plasma D-dimer levels and the International Federation of Gynaecology and Obstetrics stage (p = 0.001) or grade (p = 0.001) of CC. The study, therefore, demonstrated the potential clinical usefulness of plasma D-dimer as a diagnostic and prognostic marker of CC. |
format | Online Article Text |
id | pubmed-9937069 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cancer Intelligence |
record_format | MEDLINE/PubMed |
spelling | pubmed-99370692023-02-18 Potential clinical utility of plasma D-dimer levels among women with cervical cancer in Lagos, Nigeria Tietie, Lucky E Okunade, Kehinde S SoibI-Harry, Adaiah P John-Olabode, Sarah O Anorlu, Rose I Ecancermedicalscience Research The link between plasma D-dimer levels and underlying malignancy has been established. How this translates in clinical practice as a marker of detection and prognosis of cervical cancer (CC) is still unknown. This study compared the plasma D-dimer levels in women with and without CC and assessed the associations between plasma D-dimer levels and the stage and grade of CC. It was a comparative cross-sectional study of 65 women with histological diagnosis of CC and an equal number of age-matched cancer-free women enrolled at the University Teaching Hospital in Lagos, Nigeria. Participants’ sociodemographic and clinical data as well as venous blood samples for estimation of plasma D-dimer were collected for statistical analyses. A receiver operating characteristic (ROC) analysis is performed to select the cut-off value of plasma D-dimer for differentiating CC from non-cancer. There was a statistically significant difference in the median levels of plasma D-dimer of women with CC and their cancer-free comparison groups (3,120 (1,189–4,515) versus 210 (125–350) ng/mL; p = 0.001). A plasma D-dimer value of 543 ng/mL was chosen in a ROC analysis as the discriminatory cut-off to differentiate CC from non-cancer. There were significant associations between plasma D-dimer levels and the International Federation of Gynaecology and Obstetrics stage (p = 0.001) or grade (p = 0.001) of CC. The study, therefore, demonstrated the potential clinical usefulness of plasma D-dimer as a diagnostic and prognostic marker of CC. Cancer Intelligence 2023-01-30 /pmc/articles/PMC9937069/ /pubmed/36816787 http://dx.doi.org/10.3332/ecancer.2023.1501 Text en © the authors; licensee ecancermedicalscience. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Tietie, Lucky E Okunade, Kehinde S SoibI-Harry, Adaiah P John-Olabode, Sarah O Anorlu, Rose I Potential clinical utility of plasma D-dimer levels among women with cervical cancer in Lagos, Nigeria |
title | Potential clinical utility of plasma D-dimer levels among women with cervical cancer in Lagos, Nigeria |
title_full | Potential clinical utility of plasma D-dimer levels among women with cervical cancer in Lagos, Nigeria |
title_fullStr | Potential clinical utility of plasma D-dimer levels among women with cervical cancer in Lagos, Nigeria |
title_full_unstemmed | Potential clinical utility of plasma D-dimer levels among women with cervical cancer in Lagos, Nigeria |
title_short | Potential clinical utility of plasma D-dimer levels among women with cervical cancer in Lagos, Nigeria |
title_sort | potential clinical utility of plasma d-dimer levels among women with cervical cancer in lagos, nigeria |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9937069/ https://www.ncbi.nlm.nih.gov/pubmed/36816787 http://dx.doi.org/10.3332/ecancer.2023.1501 |
work_keys_str_mv | AT tietieluckye potentialclinicalutilityofplasmaddimerlevelsamongwomenwithcervicalcancerinlagosnigeria AT okunadekehindes potentialclinicalutilityofplasmaddimerlevelsamongwomenwithcervicalcancerinlagosnigeria AT soibiharryadaiahp potentialclinicalutilityofplasmaddimerlevelsamongwomenwithcervicalcancerinlagosnigeria AT johnolabodesaraho potentialclinicalutilityofplasmaddimerlevelsamongwomenwithcervicalcancerinlagosnigeria AT anorlurosei potentialclinicalutilityofplasmaddimerlevelsamongwomenwithcervicalcancerinlagosnigeria |